• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $MCY

    Mercury General Corporation

    Subscribe to $MCY
    $MCY
    Property-Casualty Insurers
    Finance

    Mercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance in the United States. It also writes homeowners, commercial automobile, commercial property, mechanical protection, and umbrella insurance. The company's automobile insurance products include collision, property damage, bodily injury, comprehensive, personal injury protection, underinsured and uninsured motorist, and other hazards; and homeowners' insurance products comprise dwelling, liability, personal property, fire, and other hazards. It sells its policies through a network of independent agents, insurance agencies, and direct channels in Arizona, California, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas, and Virginia. The company was founded in 1961 and is headquartered in Los Angeles, California.

    IPO Year:

    Exchange: NYSE

    Website: mercuryinsurance.com

    Recent Analyst Ratings for Mercury General Corporation

    DatePrice TargetRatingAnalyst
    2/12/2025$70.00 → $80.00Outperform → Strong Buy
    Raymond James
    7/7/2023$40.00 → $33.00Strong Buy → Outperform
    Raymond James
    11/4/2022$45.00Underperform → Strong Buy
    Raymond James
    See more ratings